Analyst Ratings for Benitec BioPharma (BNTC)
BNTC Rating Summary
BNTC Price Target Summary
- Highest: $32.00 (H.C. Wainwright)
- Lowest: $22.00 (Citizens)
- Average: $28.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$28.25 (+149.1%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
Avg. $ Target:
$28.25 (+149.1%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/7/2025 | TD Cowen » Updated 1/12/2026 |
Ritu Baral | New Coverage | Buy (N/A) |
N/A (N/A) |
13.17 (11.34) |
-13.9% | Details |
| 12/16/2024 | H.C. Wainwright » Updated 11/24/2025 |
Raghuram Selvaraju | New Coverage | Buy (Buy) |
32.00 (35.00) |
11.77 (11.34) |
-3.65% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
